CRVS Competitors & Alternatives
Compare Corvus Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
CRVS
Main Stock$14.09
Tradestie Score
43
Market Cap
$540.97M
Analyst Upside
+135.2%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$32.32
|
$1.29B | - | 50 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.74
|
$1.29B | - | 52 | Compare |
|
ZYME
Zymeworks Inc.
|
$28.77
|
$1.28B | - | 27 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$6.76
|
$1.27B | - | 47 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.38
|
$1.22B | - | 49 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$7.17
|
$1.18B | - | 42 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$61.15
|
$1.17B | - | 51 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$21.03
|
$1.15B | 4.9 | 45 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$18.08
|
$1.14B | - | 55 | Compare |
More CRVS Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
239 stocks in this industry